Clinical Trials

280 enrolled

Pancreatic Neoplasms, Cholangiocarcinoma

NCT06210724 2024-09-19

FIT in Diverticulitis

275 enrolled

Diverticulitis, Colorectal Neoplasms

NCT05645679 2024-08-12

HYBRID

Barrett Esophagus

NCT05996276 2024-08-09

SATIATION

150 enrolled

Esophageal Neoplasms, Cardiotoxicity

NCT06544083 2024-08-09

Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

300 enrolled

Disease, Carcinoma, Hepatocellular

NCT06432205 2024-05-29

The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric Cancer

121 enrolled

Stomach Neoplasms

NCT06028516 2024-04-17

MRD Application in Colorectal Cancer Patients

200 enrolled

Colorectal Neoplasms

NCT05519605 2024-04-11

BESTDRAIN

61 enrolled

Pancreatic Neoplasms, Cholangiocarcinoma

NCT06324032 2024-03-21

SunnyDay021

138 enrolled

Subepithelial Gastrointestinal Tumors

NCT06322147 2024-03-20

Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer

Colonic Neoplasms

NCT06302881 2024-03-12

Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma

207 enrolled

Pancreatic Ductal Adenocarcinoma

NCT06294873 2024-03-06

Stool Sample Collection Study

40 enrolled

Colorectal Neoplasms

NCT06289712 2024-03-04

EVALHEP

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06291779 2024-03-04

Diagnosis of Pancreatic Cancer by Purine Metabolite (Hypoxanthine, Xanthine) in Urine

120 enrolled

Disease, Pancreatic Neoplasms

NCT06177327 2024-02-29

TIM-DYS

545 enrolled

Fibrous Dysplasia of Bone, Fibrous Dysplasia, Polyostotic, Pancreatic Neoplasms

NCT06282120 2024-02-28

Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer

30 enrolled

Biliary Tract Neoplasms

NCT04923620 2024-02-26

Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy

51 enrolled

Rectal Neoplasms

NCT06277453 2024-02-26

Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy

219 enrolled

Locally Advanced Gastric Cancer

NCT06277908 2024-02-26

GASTROSTAT

700 enrolled

Stomach Neoplasms

NCT06278064 2024-02-26

Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis

562 enrolled

Esophageal Neoplasms, Stomach Neoplasms

NCT05279287 2024-02-22

VAMIS

GastrointestinalGenitourinary

Prostatic Neoplasms, Rectal Neoplasms

NCT06271109 2024-02-21

Short Term Surgical Outcomes of Anatomical Versus Non Anatomical Laparoscopic Liver Resection for Liver Tumors

Liver Neoplasms

NCT04726800 2024-02-20

CITCCA

300 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06251726 2024-02-15

COLOSAVE

310 enrolled

Colorectal Neoplasms

NCT06258434 2024-02-14

COLO-LIMULOID

1,000 enrolled

Adenoma, Colorectal Neoplasms, Adenomatous Polyps

NCT04246710 2024-02-13

Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy Samples

160 enrolled

Pancreatic Neoplasms

NCT05414383 2024-02-09

CADx

510 enrolled

Colorectal Neoplasms

NCT05173298 2024-02-07

HCC

Carcinoma, Hepatocellular

NCT05226221 2024-02-07

GESEMM

200 enrolled

Gastrointestinal Neoplasms, Gastrointestinal Hemorrhage

NCT06100003 2024-02-07

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

104 enrolled

Stomach Neoplasms

NCT06100016 2024-02-07

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

105 enrolled

Colorectal Neoplasms

NCT06247293 2024-02-07

Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy

Carcinoma, Hepatocellular, Rupture

NCT06031818 2024-02-06

Usability and Clinical Effectiveness of an Interpretable Deep Learning Framework for Post-Hepatectomy Liver Failure Prediction

80 enrolled

Carcinoma, Hepatocellular

NCT06236594 2024-02-01

Endo-mmfi

Digestive System Neoplasms, Disease, Gastrointestinal Diseases

NCT04682847 2024-01-31

Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers

40 enrolled

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT06235164 2024-01-31

The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer

585 enrolled

Locally Advanced Gastric Cancer

NCT06231160 2024-01-30

Clinical Comparative Study of Systematic Therapy Combined With MWA and Systematic Therapy for Pancreatic Cancer

185 enrolled

Pancreatic Neoplasms

NCT06231524 2024-01-30

PSN-AI

Colorectal Neoplasms

NCT03872908 2024-01-25

ELEGANT

177 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT06221423 2024-01-24

Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer

20 enrolled

Colorectal Neoplasms

NCT06218108 2024-01-23

TAUTEM-pT1

317 enrolled

Rectal Neoplasms

NCT03084770 2024-01-18

ASPEN

1,000 enrolled

Non functioning pancreatic endocrine tumor

NCT04431076 2024-01-18

PRO-PANC1

560 enrolled

Pancreatic Neoplasms

NCT06204523 2024-01-18

Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer

167 enrolled

Stomach Neoplasms

NCT04800497 2024-01-17

The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC

70 enrolled

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating

NCT06208436 2024-01-17

The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer

250 enrolled

Pancreatic Neoplasms

NCT06205732 2024-01-16

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

Carcinoma, Hepatocellular

NCT06206382 2024-01-16

Surgical Results of Resection of Locally Advanced Pancreatic Cancer

80 enrolled

Pancreatic Neoplasms

NCT06194981 2024-01-12

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

260 enrolled

Stomach Neoplasms

NCT06202781 2024-01-12

Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy

28 enrolled